OIA
CVAC

Optimum Investment Advisors’s CureVac CVAC Stock Holding History

Optimum Investment Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-50
Closed -$2K – 885
2020
Q3 		$2K Buy
+50
New +$2.79K ﹤0.01% 819

Other funds holding CVAC

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Optimum Investment Advisors's CVAC Position: Q4 2020 in Review

Optimum Investment Advisors sold out of CureVac (CVAC) in Q4 2020, closing a stake of 50 shares — an estimated $2K sold.

Optimum Investment Advisors first reported a position in CVAC in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 61 funds tracked by Wall St. Rank hold CVAC as of Q4 2020.

  • Optimum Investment Advisors reported no remaining CureVac position as of Q4 2020 after selling out during the quarter.
  • Optimum Investment Advisors sold 50 CureVac shares in Q4 2020, an estimated $2K.
  • Optimum Investment Advisors first reported a position in CureVac in Q3 2020 and held it in 1 quarter.
  • Optimum Investment Advisors's CureVac position peaked at $2K in Q3 2020.
  • 61 funds tracked by Wall St. Rank held CureVac as of Q4 2020.

Based on Optimum Investment Advisors's 13F filing for Q4 2020, filed 21 Jan 2021.